Questionnaire Survey on the Diagnosis and Treatments of Eosinophilic Gastrointestinal Diseases in Asia
Digestion · 2025
DOI: 10.1159/000544725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, 2025. Verfasst von Yoshikazu Tsuzuki und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Eosinophilia, Gastritis, Enteritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Eosinophilic gastrointestinal disease (EGID) is divided into eosinophilic esophagitis (EoE) and non-eosinophilic esophagitis eosinophilic gastrointestinal disease (non-EoE-EGID), based on the involved gastrointestinal organs. The present survey was performed to provide an overview of the current status of the epidemiology, diagnosis, and treatment of EGID in Asia.
Methods
Responses to the questionnaire were obtained from 228 doctors at various institutions in eight Asian countries. The questionnaire consisted of 52 questions on EoE and non-EoE EGID.
Results
Responses to questionnaire were obtained from 228 doctors from eight countries. The most common participation facilities were university hospitals, followed by public hospitals, private hospitals, and private clinics. 1–10 were the most frequent patients per year in each institution for both EoE and non-EoE-EGID. The 30s and 40s are common age groups for both EoE and non-EoE-EGID. Although endoscopic findings vary among countries, 15 or more eosinophil infiltrations in high-power fields as a diagnostic criterion are used in all countries for EoE. As treatments, the prescription rates of Proton pump inhibitor, diet, topical and systemic steroids, and biologics were similar among the eight countries in EoE. Non-EoE-EGID showed a similar trend to EoE in epidemiology, symptoms, diagnosis, and treatment.
Conclusion
The questionnaire survey partially revealed the current status of the epidemiology, symptoms, diagnosis, and treatment of EGID in Asian countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Saitama Medical University, Saitama, Japan.
- Department of Gastroenterology and Hepatology, Kawasaki Medical School, Okayama, Japan.
- Department of Gastroenterology, Hokkaido University Hospital, Sapporo, Japan.
- Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
- Research Center for GLOBAL and LOCAL Infectious Disease, Oita University, Oita, Japan.
- Department of Human Immunology and Nutrition Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Zitieren
APA
Tsuzuki, Y., Shiotani, A., Miyaguchi, K., Ono, S., Saito, Y., Sugimoto, M., Naito, Y., Nomura, S., Handa, O., Hisamatsu, T., Fujishiro, M., Matsuda, T., Morita, Y., Yahagi, N., Chan, F. K. L., Ang, T. L., Abdullah, M., Tablante, M. C., Prachayakul, V., …, & Imaeda, H. (2025). Questionnaire Survey on the Diagnosis and Treatments of Eosinophilic Gastrointestinal Diseases in Asia. Digestion. https://doi.org/10.1159/000544725
Vancouver
Tsuzuki Y, Shiotani A, Miyaguchi K, Ono S, Saito Y, Sugimoto M, et al. Questionnaire Survey on the Diagnosis and Treatments of Eosinophilic Gastrointestinal Diseases in Asia. Digestion. 2025. doi:10.1159/000544725
BibTeX
@article{Tsuzuki2025,
author = {Tsuzuki, Yoshikazu and Shiotani, Akiko and Miyaguchi, Kazuya and Ono, Shouko and Saito, Yutaka and Sugimoto, Mitsushige and Naito, Yuji and Nomura, Sachiyo and Handa, Osamu and Hisamatsu, Tadakazu and Fujishiro, Mitsuhiro and Matsuda, Takahisa and Morita, Yoshinori and Yahagi, Naohisa and Chan, Francis K L and Ang, Tiing Leong and Abdullah, Murdani and Tablante, Maria Carla and Prachayakul, Varayu and Li, Baiwen and Jung, Hwoon-Yong and Matsumoto, Hisashi and Shiomi, Rie and Imaeda, Hiroyuki},
title = {Questionnaire Survey on the Diagnosis and Treatments of Eosinophilic Gastrointestinal Diseases in Asia},
journal = {Digestion},
year = {2025},
doi = {10.1159/000544725}
}
EUVIMED